171 related articles for article (PubMed ID: 25899400)
1. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries.
Koljonen V; Rantanen M; Sahi H; Mellemkjær L; Hansen BT; Chen T; Hemminki K; Pukkala E
Leuk Lymphoma; 2015; 56(12):3315-9. PubMed ID: 25899400
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
3. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
4. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
Bloom R; Amber KT; Nouri K
Australas J Dermatol; 2016 Aug; 57(3):e114-6. PubMed ID: 25801041
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma and multiple primary cancers.
Howard RA; Dores GM; Curtis RE; Anderson WF; Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1545-9. PubMed ID: 16896047
[TBL] [Abstract][Full Text] [Related]
6. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E
JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005
[TBL] [Abstract][Full Text] [Related]
7. Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia.
Bzhalava D; Bray F; Storm H; Dillner J
Br J Cancer; 2011 Jan; 104(1):178-80. PubMed ID: 21081931
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M
Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432
[TBL] [Abstract][Full Text] [Related]
9. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982-2011.
Youlden DR; Youl PH; Peter Soyer H; Fritschi L; Baade PD
J Invest Dermatol; 2014 Dec; 134(12):2883-2889. PubMed ID: 24991966
[TBL] [Abstract][Full Text] [Related]
12. Second neoplasms in patients with Merkel cell carcinoma.
Brenner B; Sulkes A; Rakowsky E; Feinmesser M; Yukelson A; Bar-Haim E; Katz A; Idelevich E; Neuman A; Barhana M; Fenig E
Cancer; 2001 Apr; 91(7):1358-62. PubMed ID: 11283937
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumour.
Tadmor T; Liphshitz I; Aviv A; Landgren O; Barchana M; Polliack A
Br J Haematol; 2012 May; 157(4):457-62. PubMed ID: 22390778
[TBL] [Abstract][Full Text] [Related]
14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases.
Kukko H; Böhling T; Koljonen V; Tukiainen E; Haglund C; Pokhrel A; Sankila R; Pukkala E
Eur J Cancer; 2012 Mar; 48(5):737-42. PubMed ID: 21729823
[TBL] [Abstract][Full Text] [Related]
16. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
[TBL] [Abstract][Full Text] [Related]
17. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
18. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
Frisch M; Hjalgrim H; Olsen JH; Melbye M
Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of Merkel cell carcinoma among younger statin users.
Sahi H; Koljonen V; Böhling T; Neuvonen PJ; Vainio H; Lamminpää A; Kyyrönen P; Pukkala E
Cancer Epidemiol; 2012 Oct; 36(5):421-4. PubMed ID: 22683172
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
Hemminki K; Lenner P; Sundquist J; Bermejo JL
J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
